ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,916, issued on May 20, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors" was invented by Saleem Ahmad (Wall, N.J.), Ling Li (Pennington, N.J.), Hong Wu (New Hope, Pa.) and John Hynes (Washington Crossing, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formula (I) [INSERT CHEMICAL STRUCTURE HERE] (I) or a salt or prodrug thereof, wherein: X is CR4 or N; and R1, R2, R3, R4, and n are defined herein. Also disclosed are methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising such compounds. Thes...